9th Dimension Biotech, Inc.

BREAKING NEWS: FORZA™ now in Phase 2 Clinical Trial for Progressive Multiple Sclerosis

THE FORZA™ CLINICAL TRIAL

FORZA™ is now in a phase 2 clinical trial in Progressive Multiple Sclerosis in partnership with the Italian National Multiple Sclerosis Association and Foundation, the General Hospital of San Martino, in Genoa, Italy, and the Sant'Andrea Medical and Psychology Hospital at La Sapienza University in Rome, Italy:

OFFICIAL TITLE

Exploratory Trial of Forza™️, a Novel Nutraceutical From Actinidia Deliciosa Plants Bioengineered to Bio-encapsulate the Osmotin Plant Protein as Adjuvant for the Treatment of Progressive Multiple Sclerosis

CLINICALTRIALS.GOV

LEARN MORE ORDER NOW

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

9th Dimension Biotech, Inc.

This site uses cookies to offer you a better browsing experience

We use cookies to analyze website traffic and optimize user experience.
By accepting, you agree that your data will be aggregated with the data of all other users.

Accept